What Viasana does

Viasana (legal name UAB Viasana) is a privately held pharmaceutical services firm founded in 2005 and headquartered in Vilnius, Lithuania. It operates a representative/agency model, acting as the official Baltic partner for two global specialty pharma principals — medac GmbH (oncology-focused, across all three Baltic States since 2005) and Octapharma AG (plasma-derived medicines, in Lithuania since 2010) — and delivering an integrated suite of services covering regulatory affairs, market access, sales-force, product launches and promotional events, hospital and state tenders, distribution and logistics, pharmacovigilance, and medical-products trade extending into EU and Non-EU markets. Its stated therapeutic focus is haematology, immunology, oncology, rheumatology, and urology, and it holds GDP, EMVO, and NVVO certifications required for EU-grade pharmaceutical distribution and verification.

The company monetizes through a mix of professional-services fees (regulatory, market access, sales-force, pharmacovigilance) and transaction-based revenue from distribution, tender participation, and medical-products trade. Go-to-market is enterprise B2B: sales-led engagement with global pharma companies seeking Baltic market entry, supplemented by long-term partnerships with major wholesalers and pharmacy chains across Lithuania, Latvia, and Estonia. Pricing is quote-based and not publicly disclosed. Operating geographies explicitly cover the three Baltic states plus broader EU and Non-EU trade lanes. The company does not operate a software product, app, or API; its core technology is described as a pharmaceutical distribution and regulatory services platform, with no proprietary software features disclosed. Notable gaps include undisclosed revenue, undisclosed ownership structure, and no disclosed funding history.

Name

Viasana

Legal name

UAB Viasana

Website

https://viasana.lt

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

Viasana is a Vilnius-based, privately held pharmaceutical services firm that acts as the official Baltic representative for medac GmbH and Octapharma AG, providing regulatory, market access, sales-force, distribution, tender, and pharmacovigilance services to global pharma companies seeking entry into the Baltic States.

Ownership category

akta.pro rank

Product category

Pharmaceutical Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers (HLAIAJAK)

akta.pro secondary industries

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF), Health Supply Chain, Procurement & Access to Medicines (BPADAIAI)

Keywords

• Pharmaceutical services
• Regulatory affairs
• Market access
• Pharmaceutical distribution
• Pharmacovigilance services

Headquarters

HQ city

Vilnius

HQ country

Lithuania

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Regulatory Services: Provides regulatory services for pharmaceutical product registration and market authorization in Baltic countries
2. Sales-force Services: Provides sales-force services including launches, workshops, events, and sales promotions for pharmaceutical products
3. Distribution & Logistics: Distribution and logistics services for pharmaceutical products in Baltic Countries, EU and Non-EU countries
4. Tender Services: Participates in hospital and state tenders for pharmaceutical products
5. Market Access Services: Market access services for pharmaceutical products in Baltic markets
6. Trade of Medical Products: Participates in the trade of medical products in EU and Non-EU countries

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Viasana provides a full range of regulatory, marketing, sales-force, and distribution services for pharmaceutical products in the Baltic countries (Lithuania, Latvia, and Estonia), with extension to EU and Non-EU markets. As the official Baltic representative for medac GmbH and Octapharma AG, the company handles pharmaceutical product registration, market access, sales promotion, hospital and state tender participation, distribution and logistics, pharmacovigilance, and trade of medical products for global pharmaceutical manufacturers seeking Baltic market entry.

Product overview

Viasana offers a unified portfolio of pharmaceutical business services rather than a software product platform. The core offering comprises regulatory services, market access facilitation, sales-force services, distribution and logistics, and pharmacovigilance services—all delivered as an integrated suite for pharmaceutical companies seeking to enter or maintain presence in the Baltic States market (Lithuania, Latvia, Estonia). The company acts as the official representative for medac GmbH (since 2005) and Octapharma AG (since 2010), providing these services alongside participation in hospital and state tenders, and facilitating EU/Non-EU medical product trade.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory Services Comprehensive regulatory services covering pharmaceutical product registration, approval processes, and compliance management in Baltic countries for pharmaceutical manufacturers seeking market entry.
• Market Access Services to facilitate market entry and positioning of pharmaceutical products in the Baltic States market, supporting manufacturers in launching and growing their presence.
• Sales-Force Services Professional sales team services for promoting and selling pharmaceutical products across the Baltic region on behalf of manufacturer partners.
• Launches, Workshops, Events, and Sales Promotions Organization and execution of pharmaceutical product launches, educational workshops, industry events, and sales promotional activities in the Baltic region.
• Hospital and State Tenders Participation in hospital procurement tenders and government/state pharmaceutical procurement tenders in Baltic countries on behalf of manufacturer partners.
• Distribution and Logistics Services Comprehensive distribution and logistics services covering Baltic Countries, EU, and Non-EU countries for pharmaceutical products, leveraging wholesaler and pharmacy chain partnerships.
• Pharmacovigilance Services Adverse reaction monitoring and reporting services ensuring compliance with pharmaceutical safety regulations, including a 24/7 reporting hotline for the Baltic market.
• Medical Products Trading Trade of medical products in EU and Non-EU countries, facilitating international pharmaceutical commerce for partner manufacturers.

Named customers2 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Octapharma AGcoreStrategic or Co-development Partner · 1 January 2010Viasana is the official representative of the Swiss company Octapharma AG for Lithuania since 2010. Octapharma is a Swiss company with branches worldwide, specializing in the development and production of medicines made from blood plasma.
• medac GmbHcoreStrategic or Co-development Partner · 1 January 2005Viasana is the official representative of the German pharmaceutical company medac GmbH for the Baltic States since 2005. medac is a pharmaceutical products manufacturer with one of its main specializations in oncology, well known both in Germany and internationally.

Scale indicators4 records

Recent moves6 records

Expansion highlights3 records

Broad incumbents

• KRKA: KRKA is a Slovenian-headquartered generic pharma manufacturer with strong own-distribution presence across CEE including the Baltics. It competes with Viasana's distribution and tender services by handling its own products end-to-end in the region.
• Stada Arzneimittel: Stada is a European generics and specialty pharma group with established sales, distribution and marketing infrastructure across CEE including the Baltics. It is a broader incumbent competing for the same pharma shelf space and tender business Viasana serves.
• Sandoz: Sandoz is a global generics company with direct sales and distribution across the Baltics. As a large incumbent, it overlaps with Viasana's distribution and tender participation capabilities in the region.
• IQVIA: IQVIA is a global CRO and pharma services firm offering regulatory, market access, commercial and pharmacovigilance services. It competes with Viasana for outsourced pharma commercialization work, though at significantly larger scale and broader geographic reach.

Direct peers

• PharmaLex: PharmaLex (now part of Cencora/PharmaLex) is a regulatory affairs and pharmacovigilance services provider for pharma companies across Europe. It is directly comparable to Viasana's regulatory and pharmacovigilance service lines, though operating at broader European scale.
• Ewopharma: Ewopharma is a Central and Eastern Europe pharma commercialization partner that provides regulatory, market access, sales-force and distribution services across multiple CEE countries including the Baltics. Like Viasana, it serves as a local representative for international pharma manufacturers and offers a full-service entry model.

Others

• medac GmbH: medac is a German specialty pharma company focused on oncology, urology and rheumatology, and is itself a principal/partner of Viasana. It is relevant context as a global pharma firm that could in principle internalize Baltic operations currently delegated to Viasana.
• Octapharma AG: Octapharma is a Swiss plasma-products manufacturer and Viasana's other anchor principal partner for Lithuania. It is comparable to medac as a global pharma company whose representative mandate model determines Viasana's Lithuanian revenue base.

Regional players

• Tamro: Tamro is a leading pharmaceutical wholesaler and distribution partner in the Nordics and Baltics, offering distribution, logistics and value-added pharma services. It is a regional peer to Viasana in the Baltics pharma supply chain.
• Pharmia: Pharmia is a Nordic and Baltic pharmaceutical distribution and services company operating in Finland, the Baltics and other Nordic countries. It provides distribution, regulatory and pharmacy services comparable to Viasana's Baltic-focused offering, though with greater Nordic emphasis.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/viasana-pharma

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Viasana